Free Trial
OTCMKTS:BSTG

Biostage (BSTG) Stock Price, News & Analysis

Biostage logo
$4.45 0.00 (0.00%)
As of 07/24/2023

About Biostage Stock (OTCMKTS:BSTG)

Key Stats

Today's Range
$4.45
$4.45
50-Day Range
$4.45
$4.45
52-Week Range
$4.45
$4.45
Volume
N/A
Average Volume
1,847 shs
Market Capitalization
$61.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. The company's pipeline includes organ-regeneration technology for the repair or replacement of diseased or damaged organs, as well as product candidates to treat cancer, injury, and birth defects of the bronchus. Its lead product candidate is Biostage Esophageal Implant for the treatment of severe esophageal disease. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts.

Receive BSTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biostage and its competitors with MarketBeat's FREE daily newsletter.

BSTG Stock News Headlines

Elon Reveals Why There Soon Won’t Be Any Money For Social Security
Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.
HRGN Harvard Apparatus Regenerative Technology Inc.
Biostage to Host Investor Call
See More Headlines

BSTG Stock Analysis - Frequently Asked Questions

Biostage's stock was trading at $4.45 at the beginning of 2025. Since then, BSTG shares have increased by 0.0% and is now trading at $4.45.
View the best growth stocks for 2025 here
.

Biostage, Inc. (OTCMKTS:BSTG) released its quarterly earnings results on Thursday, August, 13th. The company reported ($0.14) earnings per share (EPS) for the quarter.

Shares of BSTG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biostage investors own include Allena Pharmaceuticals (ALNA), Fulcrum Therapeutics (FULC), Ashford Hospitality Trust (AHT), Assertio (ASRT), Adaptimmune Therapeutics (ADAP), PlayAGS (AGS) and Akebia Therapeutics (AKBA).

Company Calendar

Last Earnings
8/13/2020
Today
5/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:BSTG
Employees
7
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-6,070,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
($0.26) per share
Price / Book
-17.12

Miscellaneous

Free Float
11,758,000
Market Cap
$61.77 million
Optionable
Not Optionable
Beta
-1.02
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (OTCMKTS:BSTG) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners